Literature DB >> 145180

Mucopolysaccharide accumulation in cultured skin fibroblasts derived from patients with mucolipidosis IV.

G Bach, M Ziegler, G Kohn, M M Cohen.   

Abstract

Increased concentrations of total sulfated mucopolysaccharides (MPS), threefold, and hyaluronic acid (HA), 10-fold, were found in ML IV fibroblast extracts when compared to normal controls. Such accumulations altered the distribution of MPS:HA comprised 70% of total MPS in ML IV but only 30% in control cells. Intracellular sulfated MPS was observed accumulating almost linearly in ML IV fibroblasts. "Pulse-chase" experiments indicate that both HA and the sulfated MPS remain in the ML IV cells for long periods of time; in control cells, they are rapidly removed as low molecular weight, dialyzable fragments. These data suggest that the MPS accumulation in ML IV fibroblasts, is the consequence of a catabolic block, probably involving the lysosome.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 145180      PMCID: PMC1685507     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

1.  Accumulation of 32S-mucopolysaccharides in cultured mucolipidosis cells.

Authors:  V Hieber; J Distler; G W Jourdian; R Schmickel
Journal:  Birth Defects Orig Artic Ser       Date:  1975

2.  A modified uronic acid carbazole reaction.

Authors:  T BITTER; H M MUIR
Journal:  Anal Biochem       Date:  1962-10       Impact factor: 3.365

3.  Determination of inorganic sulphate in studies on the enzymic and non-enzymic hydrolysis of carbohydrate and other sulphate esters.

Authors:  K S DODGSON
Journal:  Biochem J       Date:  1961-02       Impact factor: 3.857

4.  A colorimetric method for the determination of glucosamine and chondrosamine.

Authors:  L A Elson; W T Morgan
Journal:  Biochem J       Date:  1933       Impact factor: 3.857

5.  Abnormal ganglioside accumulation in cultured fibroblasts from patients with mucolipidosis IV.

Authors:  G Bach; M M Cohen; G Kohn
Journal:  Biochem Biophys Res Commun       Date:  1975-10-27       Impact factor: 3.575

6.  Mucolipidosis IV: ocular, systemic, and ultrastructural findings.

Authors:  S Merin; N Livni; E R Berman; S Yatziv
Journal:  Invest Ophthalmol       Date:  1975-06

7.  A new mucolipidosis with psychomotor retardation, corneal clouding, and retinal degeneration.

Authors:  F W Newell; R Matalon; S Meyer
Journal:  Am J Ophthalmol       Date:  1975-09       Impact factor: 5.258

8.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

9.  A method for quantitative recovery of acidic glycosaminoglycans after electrophoresis on cellulose acetate strip.

Authors:  M Endo; Z Yosizawa
Journal:  Anal Biochem       Date:  1975-05-12       Impact factor: 3.365

10.  Mucolipidosis IV. Clinical, ultrastructural, histochemical, and chemical studies of a case, including a brain biopsy.

Authors:  I Tellez-Nagel; I Rapin; T Iwamoto; A B Johnson; W T Norton; H Nitowsky
Journal:  Arch Neurol       Date:  1976-12
View more
  22 in total

1.  G(M2)-ganglioside metabolism in situ in mucolipidosis IV fibroblasts.

Authors:  S Raghavan; E Leshinsky; E H Kolodny
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  Fusion of lysosomes with secretory organelles leads to uncontrolled exocytosis in the lysosomal storage disease mucolipidosis type IV.

Authors:  Soonhong Park; Malini Ahuja; Min Seuk Kim; G Cristina Brailoiu; Archana Jha; Mei Zeng; Maryna Baydyuk; Ling-Gang Wu; Christopher A Wassif; Forbes D Porter; Patricia M Zerfas; Michael A Eckhaus; Eugen Brailoiu; Dong Min Shin; Shmuel Muallem
Journal:  EMBO Rep       Date:  2015-12-18       Impact factor: 8.807

3.  Medical genetics in Israel.

Authors:  R M Goodman; B Bonne-Tamir; A Adam; R Voss; G Bach; Y Shiloh; M B Katznelson; G Barkai; B Goldman; B Padeh
Journal:  J Med Genet       Date:  1989-03       Impact factor: 6.318

4.  Mucolipidosis type IV: abnormal transport of lipids to lysosomes.

Authors:  R Bargal; G Bach
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

5.  Delayed lysosomal metabolism of lipids in mucolipidosis type IV fibroblasts after LDL-receptor-mediated endocytosis.

Authors:  S M Jansen; J E Groener; W Bax; B J Poorthuis
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

6.  Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease.

Authors:  C S Chen; G Bach; R E Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 7.  Mucolipin 1: endocytosis and cation channel--a review.

Authors:  Gideon Bach
Journal:  Pflugers Arch       Date:  2004-11-27       Impact factor: 3.657

8.  Arylsulfatase A in pseudodeficiency.

Authors:  B Herz; G Bach
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

9.  Identification of the penta-EF-hand protein ALG-2 as a Ca2+-dependent interactor of mucolipin-1.

Authors:  Silvia Vergarajauregui; Jose A Martina; Rosa Puertollano
Journal:  J Biol Chem       Date:  2009-10-28       Impact factor: 5.157

10.  Phospholipids accumulation in mucolipidosis IV cultured fibroblasts.

Authors:  R Bargal; G Bach
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.